SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE

A1

Primary syphilis

A2

Secondary syphilis

A3

Early latent syphilis

A4

Cardiovascular syphilis

A5

Neurosyphilis

A6

All other late and latent syphilis

A7A

Congenital syphilis

A10

Ocular syphilis

A11

Otosyphilis

B

Gonorrhoea

C1

Chancroid

C2

Lymphogranuloma venereum (LGV)

C3

Donovanosis

C4

Chlamydial infection

C4N

Non-specific genital infection (NSGI)

C5A

Pelvic inflammatory disease (PID) and epididymitis

C5B

Ophthalmia neonatorum

C6A

Trichomoniasis

C6B

Anaerobic/Bacterial vaginosis and anaerobic balanitis

C6C

Other vaginosis/vaginitis/balanitis

C7A

Anogenital candidosis

C8

Scabies

C9

Pediculosis pubis

C10A

Anogenital Herpes simplex: First episode

C10B

Anogenital Herpes simplex: Recurrent episode

C11A

Anogenital warts infection: First episode

C11D

Anogenital warts infection: Recurrent episode

C12

Molluscum contagiosum

C13

Viral hepatitis B (HbsAg positive): First diagnosis

C14

Viral hepatitis C: First diagnosis

C15

Viral hepatitis A: Acute infection

C16

Mycoplasma genitalium

D2A

Urinary Tract Infection

D2B

Other conditions requiring treatment at Level 3 Genitourinary Medicine Services

H

HIV positive - Previously Diagnosed

H1

New HIV diagnosis

H1A

New HIV diagnosis: Acute

H1B

New HIV diagnosis: Late infection (AIDS defined)

H2

Attendance for HIV-related care

P4A

Cervical cytology: minor abnormality

P4B

Cervical cytology: major abnormality

T1

Chlamydia test

T2

Chlamydia and gonorrhoea tests

T3

Chlamydia, gonorrhoea and syphilis tests

T4

Chlamydia, gonnorrhoea, syphilis and HIV antibody tests

T5

Herpes Simplex Virus (HSV) Test

T6

Hepatitis A/B/C Test

TS

Microscopy

TT

3 Site Testing (chlamydia and gonorrhoea)

T7

Syphilis and HIV Testing

T8

Self sampling (urinalysis/swabs) without Health Care worker (HCW) consultation

T9

STI testing not required/appropriate

T10

Rapid testing (STI and/or HIV)

T11

Chlamydia test declined

T12

Mycoplasma genitalium test

O20

Hepatitis A vaccination: 1st dose

O21

Hepatitis A vaccination: Subsequent dose

O22

Hepatitis A immune

O23

Partner notification related attendance: Hepatitis A contact

O31

PrEP eligibility criteria 1: MSM/transgender woman

O32

PrEP eligibility criteria 2: HIV positive partner

O33

PrEP eligibility criteria 3: Other high risk

O41

PrEP regimen: Starting or continuing daily Prep

O42

PrEP regimen: Starting or continuing event based Prep

O43

PrEP regimen: Continued through other source

O44

PrEP regimen: Offered and declined

O45

PrEP regimen: Stopped

O51

PrEP prescription: 30 tablets

O52

PrEP prescription: 60 tablets

O53

PrEP prescription: 90 tablets

O60

PrEP patient characteristic: Transgender

P1A

Human Immunodeficiency Virus (HIV) antibody test (no sexual health screen)

P1B

Human Immunodeficiency Virus (HIV) antibody test offered and refused

P1C

HIV test inappropriate

P2A

Hepatitis B vaccination: 1st dose

P2B

Hepatitis B vaccination: 2nd dose

P2C

Hepatitis B vaccination: 3rd dose

P2D

Hepatitis B vaccination: 4th dose

P2E

Hepatitis B vaccination: Booster

P2I

Hepatitis B immune

P3

and family planning advice (excluding condom provision)

P4

Cervical cytology done

REF1

Referral from Chlamydia Screening Programme

REF2

Referral to a Level 3 Genitourinary Medicine Service

REF3

Referral from home testing/sampling service

SG1

Shigella flexneri (group B)

SG2

Shigella sonnei (group D)

SG3

Shigella other/unspecified

SRH

Sexual and Reproductive Health PATIENT

W1

HPV vaccination: 1st dose

W2

HPV vaccination: 2nd dose

W3

HPV vaccination: 3rd dose

W4

HPV vaccination: offered and declined

W5

HPV vaccination: previously received in full

PN

Partner notification initiated related attendance

PNC

Partner notification related attendance: Chlamydia contact

PNG

Partner notification related attendance: Gonorrhoea contact

PNH

Partner notification related attendance: HIV contact

PNN

Partner notification related attendance: Non-specific genital infection contact

PNP

Partner notification related attendance: PID/Epididymitis contact

PNS

Partner notification related attendance: Syphilis contact

PNT

Partner notification related attendance: Trichomoniasis contact

PR1

Pregnant 1-12 weeks

PR2

Pregnant 13-28 weeks

PR3

Pregnant 29-40 weeks

PEPS

Post exposure prophylaxis after sexual exposure (PEPSE)

D3

Other Sexual Health and HIV Episodes  not requiring treatment

40

Sexual Assault (Acute presentation)

41

Sexual Assault (Non - acute presentation)

CSE1

Child sexual exploitation : concerns raised at internal assessment

CSE2

Child sexual exploitation : concerns raised with internal safeguarding professionals

CSE3

Child sexual exploitation : referred to external safeguarding professionals

DV

Concern of domestic violence (or abuse)

FGM

Female genital mutilation (of any type)

Z

Prisoner

SW

Sex Worker

R

Rectal infection

O

Pharyngeal infection

X

Previously diagnosed elsewhere

M

Medication given

Q

Quadrivalent HPV vaccine

A1X

Primary syphilis - previously diagnosed elsewhere

A2X

Secondary syphilis - previously diagnosed elsewhere

A3X

Early latent syphilis - previously diagnosed elsewhere

A4X

Cardiovascular syphilis - previously diagnosed elsewhere

A5X

Neurosyphillis syphilis - previously diagnosed elsewhere

A6X

All other late and latent syphilis - previously diagnosed elsewhere

A7AX

Congenital syphilis - previously diagnosed elsewhere

BR

Gonorrhoea - rectal infection

BO

Gonorrhoea - pharayngeal infection

BX

Gonorrhoea - previously diagnosed elsewhere

BM

Gonorrhoea - medication given

BRX

Gonorrhoea - rectal infection, previously diagnosed elsewhere

BRM

Gonorrhoea - rectal infection, medication given

BOX

Gonorrhoea - pharayngeal infection, previously diagnosed elsewhere

BOM

Gonorrhoea - pharayngeal infection, medication given

C4R

Chlamydia - rectal infection

C4O

Chlamydia - pharayngeal infection

C4X

Chlamydia - previously diagnosed elsewhere

C4M

Chlamydia - medication given

C4RX

Chlamydia - rectal infection, previously diagnosed elsewhere

C4RM

Chlamydia - rectal infection, medication given

C4OX

Chlamydia - rectal infection, previously diagnosed elsewhere

C4OM

Chlamydia - pharayngeal infection, medication given

C2R

Lymphogranuloma venereum (LGV) - Rectal infection

C2O

Lymphogranuloma venereum (LGV) - Pharayngeal infection

C4NR

Non-specific genital infection (NSGI) - rectal infection (proctitis)

C6AX

Trichomoniasis - previously diagnosed elsewhere

H1X

New HIV diagnosis - previously diagnosed elsewhere

H1AX

New HIV diagnosis: acute - previously diagnosed elsewhere

H1BX

New HIV diagnosis: late (AIDS defined) - previously diagnosed elsewhere

C10AM

Anogenital Herpes simplex: first episode - medication given

C10BM

Anogenital Herpes simplex: recurrent episode - medication given

C11AM

Anogenital warts infection: first episode - medication given

C11DM

Anogenital warts infection: recurrent episode - medication given

W1Q

HPV Vaccination: 1st dose - quadrivalent vaccine

W2Q

HPV Vaccination: 2nd dose - quadrivalent vaccine

W3Q

HPV Vaccination: 3rd dose - quadrivalent vaccine